{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T15:02:10Z","timestamp":1769526130579,"version":"3.49.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"publisher","award":["2020SF-088"],"award-info":[{"award-number":["2020SF-088"]}],"id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research Bulletin"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.brainresbull.2020.11.008","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T11:29:15Z","timestamp":1605266955000},"page":"145-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Exendin-4 induces a novel extended effect of ischemic tolerance via crosstalk with IGF-1R"],"prefix":"10.1016","volume":"169","author":[{"given":"Huinan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunhan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liusiyuan","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.brainresbull.2020.11.008_bib0005","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s12035-009-8081-0","article-title":"The insulin-like growth factor (IGF) receptor type 1 (IGF1R) as an essential component of the signalling network regulating neurogenesis","volume":"40","author":"Annenkov","year":"2009","journal-title":"Mol. Neurobiol."},{"issue":"3 Suppl","key":"10.1016\/j.brainresbull.2020.11.008_bib0010","first-page":"S39","article-title":"Insulin, blood glucose levels, and ischemic brain damage","volume":"51","author":"Auer","year":"1998","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.brainresbull.2020.11.008_bib0015","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/CIRCRESAHA.116.308398","article-title":"Stroke risk factors, genetics, and prevention","volume":"120","author":"Boehme","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.brainresbull.2020.11.008_bib0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.brainres.2011.10.026","article-title":"Repeated administration of exendin-4 reduces focal cerebral ischemia-induced infarction in rats","volume":"1427","author":"Briyal","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.brainresbull.2020.11.008_bib0025","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.neuroscience.2014.09.064","article-title":"Neuroprotective and anti-apoptotic effects of liraglutide in the rat brain following focal cerebral ischemia","volume":"281","author":"Briyal","year":"2014","journal-title":"Neuroscience"},{"issue":"9","key":"10.1016\/j.brainresbull.2020.11.008_bib0030","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.2337\/dc11-0291","article-title":"Effects of exenatide on measures of beta-cell function after 3 years in metformin-treated patients with type 2 diabetes","volume":"34","author":"Bunck","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.brainresbull.2020.11.008_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.tem.2016.03.017","article-title":"Perspectives in GLP-1 research: new targets, new receptors","author":"Cantini","year":"2016","journal-title":"Trends Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.brainresbull.2020.11.008_bib0040","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1073\/pnas.0610173104","article-title":"A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db\/db mice","volume":"104","author":"Chen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.brainresbull.2020.11.008_bib0045","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1038\/srep05531","article-title":"Nafamostat mesilate attenuates neuronal damage in a rat model of transient focal cerebral ischemia through thrombin inhibition","volume":"4","author":"Chen","year":"2014","journal-title":"Sci. Rep."},{"issue":"14","key":"10.1016\/j.brainresbull.2020.11.008_bib0050","doi-asserted-by":"crossref","first-page":"10538","DOI":"10.1074\/jbc.M109.091116","article-title":"Glucagon-like peptide-1 increases beta-cell glucose competence and proliferation by translational induction of insulin-like growth factor-1 receptor expression","volume":"285","author":"Cornu","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.brainresbull.2020.11.008_bib0055","doi-asserted-by":"crossref","first-page":"e103114","DOI":"10.1371\/journal.pone.0103114","article-title":"Exendin-4 reduces ischemic brain injury in normal and aged type 2 diabetic mice and promotes microglial M2 polarization","volume":"9","author":"Darsalia","year":"2014","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.brainresbull.2020.11.008_bib0060","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11154-014-9285-9","article-title":"GLP-1R activation for the treatment of stroke: updating and future perspectives","volume":"15","author":"Darsalia","year":"2014","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"5","key":"10.1016\/j.brainresbull.2020.11.008_bib0065","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/jcbfm.2015.17","article-title":"Glucagon-like receptor 1 agonists and DPP-4 inhibitors: potential therapies for the treatment of stroke","volume":"35","author":"Darsalia","year":"2015","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"Pt B","key":"10.1016\/j.brainresbull.2020.11.008_bib0070","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neuropharm.2017.08.022","article-title":"Glucagon-like receptor 1 agonists and DPP-4 inhibitors: anti-diabetic drugs with anti-stroke potential","volume":"136","author":"Darsalia","year":"2018","journal-title":"Neuropharmacology"},{"issue":"4","key":"10.1016\/j.brainresbull.2020.11.008_bib0075","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1474-4422(09)70054-7","article-title":"Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use","volume":"8","author":"Dirnagl","year":"2009","journal-title":"Lancet Neurol."},{"issue":"9961","key":"10.1016\/j.brainresbull.2020.11.008_bib0080","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/S0140-6736(14)61335-0","article-title":"Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis","volume":"384","author":"Eng","year":"2014","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.brainresbull.2020.11.008_bib0085","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.brainresrev.2009.09.006","article-title":"The role and regulation of hypoxia-inducible factor-1alpha expression in brain development and neonatal hypoxic-ischemic brain injury","volume":"62","author":"Fan","year":"2009","journal-title":"Brain Res. Rev."},{"issue":"9913","key":"10.1016\/j.brainresbull.2020.11.008_bib0090","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0140-6736(13)61953-4","article-title":"Global and regional burden of stroke during 1990-2010: findings from the Global Burden of Disease Study 2010","volume":"383","author":"Feigin","year":"2014","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.brainresbull.2020.11.008_bib0095","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S1474-4422(15)00054-X","article-title":"Future directions of acute ischaemic stroke therapy","volume":"14","author":"Fisher","year":"2015","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.brainresbull.2020.11.008_bib0100","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1042\/BST20150244","article-title":"The complexity of signalling mediated by the glucagon-like peptide-1 receptor","volume":"44","author":"Fletcher","year":"2016","journal-title":"Biochem. Soc. Trans."},{"issue":"533","key":"10.1016\/j.brainresbull.2020.11.008_bib0105","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay8071","article-title":"GABA neurons in the nucleus tractus solitarius express GLP-1 receptors and mediate anorectic effects of liraglutide in rats","volume":"12","author":"Fortin","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"3","key":"10.1016\/j.brainresbull.2020.11.008_bib0110","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1124\/jpet.110.175752","article-title":"Pharmacokinetic and pharmacodynamic modeling of exendin-4 in type 2 diabetic Goto-Kakizaki rats","volume":"336","author":"Gao","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.brainresbull.2020.11.008_bib0115","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jstrokecerebrovasdis.2006.05.011","article-title":"Alteration of insulin-like growth factor-1 expression after middle cerebral artery occlusion in monkeys and rats: complementary DNA microarray, immunohistochemistry, and in situ hybridization studies","volume":"15","author":"Gao","year":"2006","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"10.1016\/j.brainresbull.2020.11.008_bib0120","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fendo.2013.00050","article-title":"Acting on hormone receptors with minimal side effect on cell proliferation: a timely challenge illustrated with GLP-1R and GPER","volume":"4","author":"Gigoux","year":"2013","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"6","key":"10.1016\/j.brainresbull.2020.11.008_bib0125","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.pneurobio.2003.08.002","article-title":"Insulin-like growth factor-1 and post-ischemic brain injury","volume":"70","author":"Guan","year":"2003","journal-title":"Prog. Neurobiol."},{"issue":"10","key":"10.1016\/j.brainresbull.2020.11.008_bib0130","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2165\/11635890-000000000-00000","article-title":"Potential role of glucagon-like peptide-1 (GLP-1) in neuroprotection","volume":"26","author":"Holscher","year":"2012","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1016\/j.brainresbull.2020.11.008_bib0135","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1530\/eje.0.1460863","article-title":"The short half-life of glucagon-like peptide-1 in plasma does not reflect its long-lasting beneficial effects","volume":"146","author":"Hui","year":"2002","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"10.1016\/j.brainresbull.2020.11.008_bib0140","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.neuint.2003.10.006","article-title":"Expression and changes of endogenous insulin-like growth factor-1 in neurons and glia in the gerbil hippocampus and dentate gyrus after ischemic insult","volume":"45","author":"Hwang","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.brainresbull.2020.11.008_bib0145","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.phrs.2015.10.008","article-title":"Peptidic exenatide and herbal catalpol mediate neuroprotection via the hippocampal GLP-1 receptor\/\u03b2-endorphin pathway","volume":"102","author":"Jia","year":"2015","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.brainresbull.2020.11.008_bib0150","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1161\/STROKEAHA.116.012934","article-title":"Exendin-4 inhibits matrix Metalloproteinase-9 activation and reduces infarct growth after focal cerebral ischemia in hyperglycemic mice","volume":"47","author":"Kuroki","year":"2016","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.brainresbull.2020.11.008_bib0155","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1111\/jdi.12932","article-title":"Prevalence of diabetes and its effects on stroke outcomes: a meta-analysis and literature review","volume":"10","author":"Lau","year":"2019","journal-title":"J. Diabetes Investig."},{"issue":"4","key":"10.1016\/j.brainresbull.2020.11.008_bib0160","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1073\/pnas.0806720106","article-title":"GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism","volume":"106","author":"Li","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"3","key":"10.1016\/j.brainresbull.2020.11.008_bib0165","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.clinthera.2015.01.003","article-title":"Emerging new therapies for the treatment of type 2 diabetes mellitus: glucagon-like peptide-1 receptor agonists","volume":"37","author":"Lindamood","year":"2015","journal-title":"Clin. Ther."},{"issue":"1","key":"10.1016\/j.brainresbull.2020.11.008_bib0170","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/01.STR.20.1.84","article-title":"Reversible middle cerebral artery occlusion without craniectomy in rats","volume":"20","author":"Longa","year":"1989","journal-title":"Stroke"},{"issue":"10","key":"10.1016\/j.brainresbull.2020.11.008_bib0175","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1463-1326.2009.01070.x","article-title":"Poly-GLP-1, a novel long-lasting glucagon-like peptide-1 polymer, ameliorates hyperglycaemia by improving insulin sensitivity and increasing pancreatic beta-cell proliferation","volume":"11","author":"Ma","year":"2009","journal-title":"Diabetes Obes. Metab."},{"issue":"14","key":"10.1016\/j.brainresbull.2020.11.008_bib0180","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1001\/jama.2015.3058","article-title":"Acute stroke intervention: a systematic review","volume":"313","author":"Prabhakaran","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.brainresbull.2020.11.008_bib0185","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12974-019-1638-6","article-title":"The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke","volume":"16","author":"Shan","year":"2019","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.brainresbull.2020.11.008_bib0190","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s10571-012-9803-9","article-title":"Hypoxia inducible factor-1: its potential role in cerebral ischemia","volume":"32","author":"Singh","year":"2012","journal-title":"Cell. Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.brainresbull.2020.11.008_bib0195","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/sj.jcbfm.9600606","article-title":"Toll-like receptor 9: a new target of ischemic preconditioning in the brain","volume":"28","author":"Stevens","year":"2008","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"8","key":"10.1016\/j.brainresbull.2020.11.008_bib0200","doi-asserted-by":"crossref","first-page":"e2892","DOI":"10.1371\/journal.pone.0002892","article-title":"Boc5, a non-peptidic glucagon-like Peptide-1 receptor agonist, invokes sustained glycemic control and weight loss in diabetic mice","volume":"3","author":"Su","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.brainresbull.2020.11.008_bib0205","article-title":"Cerebral ischemic preconditioning: the road so far","author":"T.V. N","year":"2015","journal-title":"Mol. Neurobiol."},{"issue":"6","key":"10.1016\/j.brainresbull.2020.11.008_bib0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2020.05.001","article-title":"GLP-1 receptor signaling in astrocytes regulates fatty acid oxidation, mitochondrial integrity, and function","volume":"31","author":"Timper","year":"2020","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.brainresbull.2020.11.008_bib0215","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.2337\/diabetes.51.5.1443","article-title":"Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the beta-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4","volume":"51","author":"Tourrel","year":"2002","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.brainresbull.2020.11.008_bib0220","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/jcbfm.1991.168","article-title":"Insulin attenuates ischemic brain damage independent of its hypoglycemic effect","volume":"11","author":"Voll","year":"1991","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"9834","key":"10.1016\/j.brainresbull.2020.11.008_bib0225","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/S0140-6736(12)60738-7","article-title":"Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis","volume":"379","author":"Wardlaw","year":"2012","journal-title":"Lancet"},{"issue":"9633","key":"10.1016\/j.brainresbull.2020.11.008_bib0230","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0140-6736(08)60878-8","article-title":"An estimation of the global volume of surgery: a modelling strategy based on available data","volume":"372","author":"Weiser","year":"2008","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.brainresbull.2020.11.008_bib0235","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1161\/STROKEAHA.112.665331","article-title":"Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systematic review and meta-analysis of 55 studies","volume":"43","author":"Whiteley","year":"2012","journal-title":"Stroke"},{"issue":"3","key":"10.1016\/j.brainresbull.2020.11.008_bib0240","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s12640-009-9060-y","article-title":"IGF-1 and pAKT signaling promote hippocampal CA1 neuronal survival following injury to dentate granule cells","volume":"16","author":"Wine","year":"2009","journal-title":"Neurotox. Res."},{"issue":"1","key":"10.1016\/j.brainresbull.2020.11.008_bib0245","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12933-019-0874-5","article-title":"Effect of pioglitazone in acute ischemic stroke patients with diabetes mellitus: a nested case-control study","volume":"18","author":"Woo","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"issue":"12","key":"10.1016\/j.brainresbull.2020.11.008_bib0250","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.2337\/diabetes.48.12.2270","article-title":"Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats","volume":"48","author":"Xu","year":"1999","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.brainresbull.2020.11.008_bib0255","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/jamaneurol.2014.1210","article-title":"Symptomatic intracerebral hemorrhage in acute ischemic stroke after thrombolysis with intravenous recombinant tissue plasminogen activator: a review of natural history and treatment","volume":"71","author":"Yaghi","year":"2014","journal-title":"JAMA Neurol."},{"issue":"5","key":"10.1016\/j.brainresbull.2020.11.008_bib0260","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.2337\/diabetes.48.5.1026","article-title":"Glucose-lowering and insulin-sensitizing actions of exendin-4: studies in obese diabetic (ob\/ob, db\/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta)","volume":"48","author":"Young","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.brainresbull.2020.11.008_bib0265","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2011.10.046","article-title":"IGF-1 induces hypoxia-inducible factor 1alpha-mediated GLUT3 expression through PI3K\/Akt\/mTOR dependent pathways in PC12 cells","volume":"1430","author":"Yu","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.brainresbull.2020.11.008_bib0270","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejps.2015.01.010","article-title":"Pro-GLP-1, a Pro-drug of GLP-1, is neuroprotective in cerebral ischemia","volume":"70","author":"Zhang","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.brainresbull.2020.11.008_bib0275","doi-asserted-by":"crossref","first-page":"e0148827","DOI":"10.1371\/journal.pone.0148827","article-title":"An orally active allosteric GLP-1 receptor agonist is neuroprotective in cellular and rodent models of stroke","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.brainresbull.2020.11.008_bib0280","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1208\/s12248-015-9854-1","article-title":"Intranasal delivery of Exendin-4 confers neuroprotective effect against cerebral ischemia in mice","volume":"18","author":"Zhang","year":"2016","journal-title":"AAPS J."},{"key":"10.1016\/j.brainresbull.2020.11.008_bib0285","doi-asserted-by":"crossref","first-page":"549412","DOI":"10.1155\/2015\/549412","article-title":"Hypoxia-inducible Factor-1 in physiological and pathophysiological angiogenesis: applications and therapies","volume":"2015","author":"Zimna","year":"2015","journal-title":"Biomed Res. Int."},{"issue":"5","key":"10.1016\/j.brainresbull.2020.11.008_bib0290","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/STROKEAHA.116.015756","article-title":"Empagliflozin and cerebrovascular events in patients with type 2 diabetes mellitus at high cardiovascular risk","volume":"48","author":"Zinman","year":"2017","journal-title":"Stroke"}],"container-title":["Brain Research Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923020306948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0361923020306948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:43:59Z","timestamp":1759783439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0361923020306948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":58,"alternative-id":["S0361923020306948"],"URL":"https:\/\/doi.org\/10.1016\/j.brainresbull.2020.11.008","relation":{},"ISSN":["0361-9230"],"issn-type":[{"value":"0361-9230","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exendin-4 induces a novel extended effect of ischemic tolerance via crosstalk with IGF-1R","name":"articletitle","label":"Article Title"},{"value":"Brain Research Bulletin","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainresbull.2020.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}